SCHEDULE: OrbiMed Discloses 6% Stake in SI-BONE Inc.

OrbiMed Capital LLC and OrbiMed Advisors LLC have disclosed a combined 6.0% beneficial ownership stake in SI-BONE, Inc. common stock.

Summary

• OrbiMed Capital LLC and OrbiMed Advisors LLC collectively hold 6.0% of SI-BONE, Inc.'s common stock.
• OrbiMed Capital LLC beneficially owns 2,184,200 shares, representing 5.1% of the class, with sole voting and dispositive power.
• OrbiMed Advisors LLC beneficially owns 394,779 shares, representing 0.9% of the class, with shared voting and dispositive power.
• The shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The filing is a routine disclosure of a significant institutional ownership stake, which can be viewed as a vote of confidence by a major investor. No negative information is presented.

Positives

• The disclosure of a significant institutional stake by OrbiMed, a specialized healthcare investor, can be interpreted as a signal of confidence in SI-BONE, Inc.

Future Outlook

No forward-looking statements or guidance are provided in this beneficial ownership disclosure.

Industry Context

This filing indicates continued institutional investment interest in the medical device sector, specifically in companies like SI-BONE, Inc., which operates in the orthopedic space.

Stakeholder Impact

• Shareholders: Increased transparency regarding significant institutional holdings. Potential positive signal of institutional confidence.

Key Dates

Recommendation

The filing is a routine disclosure of a significant institutional ownership stake by OrbiMed, a specialized healthcare investor. While the presence of a major institutional holder can be a positive signal of confidence in SI-BONE, Inc., this filing alone does not provide sufficient financial or operational data to warrant a 'buy' or 'sell' recommendation. It primarily offers transparency on a substantial existing position, suggesting a 'hold' for investors awaiting further fundamental updates.

Keywords

SI-BONE Inc., OrbiMed Capital, OrbiMed Advisors, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Medical Devices, Orthopedics